[go: up one dir, main page]

MX2017009799A - Capsulas compuestas que comprenden raloxifeno y vitamina d o sus derivados. - Google Patents

Capsulas compuestas que comprenden raloxifeno y vitamina d o sus derivados.

Info

Publication number
MX2017009799A
MX2017009799A MX2017009799A MX2017009799A MX2017009799A MX 2017009799 A MX2017009799 A MX 2017009799A MX 2017009799 A MX2017009799 A MX 2017009799A MX 2017009799 A MX2017009799 A MX 2017009799A MX 2017009799 A MX2017009799 A MX 2017009799A
Authority
MX
Mexico
Prior art keywords
vitamin
raloxifen
derivatives
layer
composite capsules
Prior art date
Application number
MX2017009799A
Other languages
English (en)
Other versions
MX391640B (es
Inventor
Hyun Park Jae
Soo Woo Jong
Kwan Kwon Taek
Ii Kim Yong
Hun Kim Young
Young Park Jin
Bin YOUN Seung
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of MX2017009799A publication Critical patent/MX2017009799A/es
Publication of MX391640B publication Critical patent/MX391640B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proporciona una cápsula compuesta y un método para preparar la misma. La cápsula compuesta incluye: una capa separada de raloxifeno que incluye raloxifeno o una sal aceptable farmacéuticamente del mismo; y una capa separada de vitamina D que incluye vitamina D o un derivado de la misma, en donde la capa separada de raloxifeno y la capa separada de vitamina D están separadas entre si en la cápsula compuesta.
MX2017009799A 2015-01-28 2016-01-28 Capsulas compuestas que comprenden raloxifeno y vitamina d o sus derivados. MX391640B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150013537 2015-01-28
PCT/KR2016/000959 WO2016122236A1 (en) 2015-01-28 2016-01-28 Composite capsules comprising raloxifene, and vitamin d or its derivatives

Publications (2)

Publication Number Publication Date
MX2017009799A true MX2017009799A (es) 2018-01-18
MX391640B MX391640B (es) 2025-03-21

Family

ID=56543765

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009799A MX391640B (es) 2015-01-28 2016-01-28 Capsulas compuestas que comprenden raloxifeno y vitamina d o sus derivados.

Country Status (10)

Country Link
US (1) US20170368049A1 (es)
KR (1) KR102548747B1 (es)
CN (1) CN107206011B (es)
BR (1) BR112017016042A2 (es)
HK (1) HK1244673A1 (es)
MX (1) MX391640B (es)
MY (1) MY190876A (es)
PH (1) PH12017501314A1 (es)
RU (1) RU2017126111A (es)
WO (1) WO2016122236A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102612983B1 (ko) * 2016-09-30 2023-12-13 한미약품 주식회사 용출율이 향상된 라록시펜, 및 비타민 d 또는 그 유도체를 포함하는 복합 캡슐제 및 이의 제조방법
KR20180112139A (ko) * 2017-03-30 2018-10-12 한미약품 주식회사 바제독시펜 또는 그의 약제학적으로 허용가능한 염, 및 콜레칼시페롤 또는 그의 약제학적으로 허용가능한 염을 포함하는 복합제제
KR102351931B1 (ko) * 2020-12-30 2022-01-17 주식회사유한양행 라록시펜 염산염을 포함하는 약학 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US20040170687A1 (en) * 2003-02-27 2004-09-02 Integrity Pharmaceutical Corporation Compositions with improved stability and methods of formulation thereof
KR100822133B1 (ko) * 2006-11-06 2008-04-15 한미약품 주식회사 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제
WO2009080364A1 (en) * 2007-12-21 2009-07-02 Synthon B.V. Raloxifene composition
US8501690B2 (en) * 2010-04-30 2013-08-06 John G. Stark Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue
KR20110132116A (ko) * 2010-06-01 2011-12-07 (주)국전약품 라록시펜 염산염을 포함하는 고체분산체, 이의 제조방법, 및 이를 포함하는 경구용 제제
KR101230178B1 (ko) * 2010-06-10 2013-02-06 주식회사 네비팜 골다공증 예방 또는 치료용 조성물 및 이의 제조방법
AU2014201820B2 (en) * 2013-03-27 2016-05-19 Psm Healthcare Limited Stabilized vitamin D formulations
UA118110C2 (uk) * 2013-06-28 2018-11-26 Ханмі Фарм. Ко., Лтд. Фармацевтичний комбінований склад капсули, який містить тадалафіл і тамсулозин

Also Published As

Publication number Publication date
WO2016122236A1 (en) 2016-08-04
US20170368049A1 (en) 2017-12-28
PH12017501314A1 (en) 2018-02-05
KR20160092956A (ko) 2016-08-05
BR112017016042A2 (pt) 2018-04-03
CN107206011B (zh) 2020-10-20
RU2017126111A (ru) 2019-02-28
KR102548747B1 (ko) 2023-06-29
MY190876A (en) 2022-05-13
HK1244673A1 (zh) 2018-08-17
CN107206011A (zh) 2017-09-26
MX391640B (es) 2025-03-21

Similar Documents

Publication Publication Date Title
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
IL269444B (en) New modified indazoles, methods for their production, pharmaceutical preparations containing the new modified indazoles, and the use of the new modified indazoles in the production of drugs
CO2017012893A2 (es) Composiciones farmacéuticas que comprenden péptidos neo-antígenos o una sal de los mismos y métodos para preparar las mismas
ITUB20160477A1 (it) Apparecchiatura per la preparazione di bevande utilizzando capsule contenenti una sostanza alimentare
LT3457871T (lt) Kapsulė tabako pramonės gaminiui
IL264624A (en) System, apparatus, method, capsule and kit of capsules for preparing a beverage
UY36275A (es) Compuestos aminopirimidinilo
HUE061758T2 (hu) Új hidroxisav-származékok, eljárás elõállításukra és ezeket tartalmazó gyógyszerkészítmények
EP3793505A4 (en) Quick release capsules
AR103091A1 (es) Cápsulas que contienen microapuntalante y una sustancia para producir eventos microsísmicos
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
ITUB20161103A1 (it) Capsula per la preparazione di bevande
BR112017004106A2 (pt) núcleos absorventes fixos e removíveis para artigos absorventes
MA54318A (fr) Formulations de capsules
PT3242933T (pt) Células estaminais mesenquimais geneticamente modificadas que expressam alfa-1 antitripsina (aat)
NZ725577A (en) Modified release coated capsules
IT201700084351A1 (it) Apparecchiatura per la preparazione di bevande utilizzando capsule contenenti una sostanza alimentare
NZ725578A (en) Modified release coated capsules
MX2017009799A (es) Capsulas compuestas que comprenden raloxifeno y vitamina d o sus derivados.
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
PT3514073T (pt) Método para embalar cápsulas alimentares e produto alimentar embalado produzido por meio das mesmas
IT201700029991A1 (it) Capsula per la preparazione di una bevanda
EP3375438A4 (en) PREGABALIN CONTAINING TRIPLE EXTENDED RELEASE ORAL TABLET
ITUB20153482A1 (it) Nastro composito tridimensionale, procedimento ed apparecchio per la sua produzione
IL245492B (en) Method of mechanical separation for a double layer transfer